|
#
|
Entity
|
Type
|
Relation
|
Support
|
Relative specificity
|
|
1
|
PPARD gene
|
Gene
|
Known
|
Explain
|
|
|
2
|
NOS3 gene
|
Gene
|
Known
|
Explain
|
|
|
3
|
AKT1 gene
|
Gene
|
Known
|
Explain
|
|
|
4
|
GW0742
|
Compound
|
Inferred
|
Explain
|
|
|
5
|
linoleic acid binding
|
Function
|
Inferred
|
Explain
|
|
|
6
|
norathyriol
|
Compound
|
Inferred
|
Explain
|
|
|
7
|
positive regulation of vasodilation
|
Function
|
Inferred
|
Explain
|
|
|
8
|
negative regulation of smooth muscle cell proliferation
|
Function
|
Inferred
|
Explain
|
|
|
9
|
antimonite
|
Compound
|
Inferred
|
Explain
|
|
|
10
|
anagen
|
Function
|
Inferred
|
Explain
|
|
|
11
|
monobutyl phthalate
|
Compound
|
Inferred
|
Explain
|
|
|
12
|
Peroxisome proliferator-activated receptor, beta
|
Domain
|
Inferred
|
Explain
|
|
|
13
|
keratinocyte migration
|
Function
|
Inferred
|
Explain
|
|
|
14
|
GSK0660
|
Compound
|
Inferred
|
Explain
|
|
|
15
|
Peroxisome proliferator-activated receptor
|
Domain
|
Inferred
|
Explain
|
|
|
16
|
cell-substrate adhesion
|
Function
|
Inferred
|
Explain
|
|
|
17
|
mono-(2-ethylhexyl)phthalate
|
Compound
|
Inferred
|
Explain
|
|
|
18
|
positive regulation of fat cell differentiation
|
Function
|
Inferred
|
Explain
|
|
|
19
|
positive regulation of epidermis development
|
Function
|
Inferred
|
Explain
|
|
|
20
|
tetradecylselenoacetic acid
|
Compound
|
Inferred
|
Explain
|
|
|
21
|
mRNA transcription
|
Function
|
Inferred
|
Explain
|
|
|
22
|
negative regulation of smooth muscle cell migration
|
Function
|
Inferred
|
Explain
|
|
|
23
|
fatty acid binding
|
Function
|
Inferred
|
Explain
|
|
|
24
|
keratinocyte proliferation
|
Function
|
Inferred
|
Explain
|
|
|
25
|
negative regulation of collagen biosynthetic process
|
Function
|
Inferred
|
Explain
|
|
|
26
|
Adipogenesis
|
Function
|
Inferred
|
Explain
|
|
|
27
|
response to vitamin A
|
Function
|
Inferred
|
Explain
|
|
|
28
|
tyrphostin AG 1478
|
Compound
|
Inferred
|
Explain
|
|
|
29
|
NF-kappaB binding
|
Function
|
Inferred
|
Explain
|
|
|
30
|
vitamin A metabolism
|
Function
|
Inferred
|
Explain
|
|
|
31
|
nitric oxide biosynthetic process
|
Function
|
Inferred
|
Explain
|
|
|
32
|
nitric oxide metabolic process
|
Function
|
Inferred
|
Explain
|
|
|
33
|
Decidual Cell Reaction
|
Function
|
Inferred
|
Explain
|
|
|
34
|
fatty acid transport
|
Function
|
Inferred
|
Explain
|
|
|
35
|
positive regulation of phosphoinositide 3-kinase cascade
|
Function
|
Inferred
|
Explain
|
|
|
36
|
axon ensheathment
|
Function
|
Inferred
|
Explain
|
|
|
37
|
response to fluid shear stress
|
Function
|
Inferred
|
Explain
|
|
|
38
|
steroid hormone mediated signaling pathway
|
Function
|
Inferred
|
Explain
|
|
|
39
|
regulation of nitric-oxide synthase activity
|
Function
|
Inferred
|
Explain
|
|
|
40
|
JM 3100
|
Compound
|
Inferred
|
Explain
|
|
|
41
|
Acute myeloid leukemia - Homo sapiens (human)
|
Pathway
|
Inferred
|
Explain
|
|
|
42
|
Nuclear hormone receptor, ligand-binding, core
|
Domain
|
Inferred
|
Explain
|
|
|
43
|
ligand-dependent nuclear receptor activity
|
Function
|
Inferred
|
Explain
|
|
|
44
|
Cruveilhier-Baumgarten Syndrome
|
Disease
|
Inferred
|
Explain
|
|
|
45
|
proteoglycan metabolic process
|
Function
|
Inferred
|
Explain
|
|
|
46
|
Diethylhexyl Phthalate
|
Compound
|
Inferred
|
Explain
|
|
|
47
|
sinapinic acid
|
Compound
|
Inferred
|
Explain
|
|
|
48
|
Nuclear hormone receptor, ligand-binding
|
Domain
|
Inferred
|
Explain
|
|
|
49
|
Nitric oxide synthase, oxygenase region
|
Domain
|
Inferred
|
Explain
|
|
|
50
|
N-(omega)-Hydroxyarginine
|
Compound
|
Inferred
|
Explain
|
|
|
51
|
2-butylamino-2-demethoxy-hypocrellin B
|
Compound
|
Inferred
|
Explain
|
|
|
52
|
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
|
Compound
|
Inferred
|
Explain
|
|
|
53
|
Placentation
|
Function
|
Inferred
|
Explain
|
|
|
54
|
response to activity
|
Function
|
Inferred
|
Explain
|
|
|
55
|
fatty acid catabolic process
|
Function
|
Inferred
|
Explain
|
|
|
56
|
nebivolol
|
Compound
|
Inferred
|
Explain
|
|
|
57
|
Blastocyst Implantation, natural
|
Function
|
Inferred
|
Explain
|
|
|
58
|
nitric oxide synthase activity
|
Function
|
Inferred
|
Explain
|
|
|
59
|
Zinc finger, nuclear hormone receptor-type
|
Domain
|
Inferred
|
Explain
|
|
|
60
|
hyperoside
|
Compound
|
Inferred
|
Explain
|
|
|
61
|
Nitric-oxide synthase
|
Domain
|
Inferred
|
Explain
|
|
|
62
|
Intestinal Perforation
|
Disease
|
Inferred
|
Explain
|
|
|
63
|
IPR023173
|
Domain
|
Inferred
|
Explain
|
|
|
64
|
Steroid hormone receptor
|
Domain
|
Inferred
|
Explain
|
|
|
65
|
positive regulation of insulin secretion
|
Function
|
Inferred
|
Explain
|
|
|
66
|
arginine binding
|
Function
|
Inferred
|
Explain
|
|
|
67
|
tetrahydrobiopterin binding
|
Function
|
Inferred
|
Explain
|
|
|
68
|
smooth muscle hyperplasia
|
Function
|
Inferred
|
Explain
|
|
|
69
|
SPEN gene
|
Gene
|
Inferred
|
Explain
|
|
|
70
|
11-(4-dimethylaminophenyl)-6-methyl-4',5'-dihydro(estra-4,9-diene-17,2'-(3H)-furan)-3-one
|
Compound
|
Inferred
|
Explain
|
|
|
71
|
4-coumaric acid
|
Compound
|
Inferred
|
Explain
|
|
|
72
|
N,N-diacetylcystine
|
Compound
|
Inferred
|
Explain
|
|
|
73
|
NOSTRIN gene
|
Gene
|
Inferred
|
Explain
|
|
|
74
|
steroid hormone receptor activity
|
Function
|
Inferred
|
Explain
|
|
|
75
|
sulindac sulfone
|
Compound
|
Inferred
|
Explain
|
|
|
76
|
Zinc finger, NHR/GATA-type
|
Domain
|
Inferred
|
Explain
|
|
|
77
|
fatty acid beta-oxidation
|
Function
|
Inferred
|
Explain
|
|
|
78
|
regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor
|
Function
|
Inferred
|
Explain
|
|
|
79
|
GADD45B gene
|
Gene
|
Inferred
|
Explain
|
|
|
80
|
Isosorbide Dinitrate
|
Compound
|
Inferred
|
Explain
|
|
|
81
|
RXRG gene
|
Gene
|
Inferred
|
Explain
|
|
|
82
|
Lactic acid
|
Compound
|
Inferred
|
Explain
|
|
|
83
|
FAD-binding, type 1
|
Domain
|
Inferred
|
Explain
|
|
|
84
|
desethylamiodarone
|
Compound
|
Inferred
|
Explain
|
|
|
85
|
negative regulation of epithelial cell proliferation
|
Function
|
Inferred
|
Explain
|
|
|
86
|
15-deoxy-delta(12,14)-prostaglandin J2
|
Compound
|
Inferred
|
Explain
|
|
|
87
|
Coronary Artery Vasospasm
|
Disease
|
Inferred
|
Explain
|
|
|
88
|
malvidin chloride
|
Compound
|
Inferred
|
Explain
|
|
|
89
|
Vanillic Acid
|
Compound
|
Inferred
|
Explain
|
|
|
90
|
anthra(1,9-cd)pyrazol-6(2H)-one
|
Compound
|
Inferred
|
Explain
|
|
|
91
|
Ischemic stroke
|
Disease
|
Inferred
|
Explain
|
|
|
92
|
Flavodoxin-like
|
Domain
|
Inferred
|
Explain
|
|
|
93
|
Alprostadil
|
Compound
|
Inferred
|
Explain
|
|
|
94
|
GADD45G gene
|
Gene
|
Inferred
|
Explain
|
|
|
95
|
HDAC7 gene
|
Gene
|
Inferred
|
Explain
|
|
|
96
|
glucose transport
|
Function
|
Inferred
|
Explain
|
|
|
97
|
NCOR2 gene
|
Gene
|
Inferred
|
Explain
|
|
|
98
|
3-methylquercetin
|
Compound
|
Inferred
|
Explain
|
|
|
99
|
Roxarsone
|
Compound
|
Inferred
|
Explain
|
|
|
100
|
negative regulation of muscle hyperplasia
|
Function
|
Inferred
|
Explain
|
|